Morinda citrifolia based antimicrobial formulations
WO2009099840A2
Methods of manufacture of morinda citrifolia based compositions for treatment of anti-inflammatory diseases through inhibition of cox-1, cox-2, interleukin-1beta, interleukin-6, tnf-alpha, hle, and inos
WO2009032851A2
Morinda citrifolia based formulations for regulating t cell immunomodulation in neonatal stock animals
WO2009006565A2
Formulations and methods for inhibiting anaerobes, gram negative bacteria, protozoa and other microbial growth with morinda citrifolia l. enhanced formulations
WO2008106405A1
Administration of morinda citrifolia l. based formulations to increase birth rates
WO2008067410A2
Lipoxygenase and cyclooxygenase inhibition
EP2018104A1
Method and composition for administering bioactive compounds derived from morinda citrifolia
KR20080088641A
Morinda citrifolia enhanced products for administration to animal
EP1962874A2
MORINDA CITRIFOLIA BASED COMPOSITIONS FOR TREATMENT OF ANTI-INFLAMATORY DISEASES THROUGH INHIBITION OF COX-1, COX-2, INTERLEUKIN-1BETA , INTERLEUKIN-6, TNF-ALPHA , HLE, AND iNOS
WO2007064601A2
Antiviral morinda citrifolia l. based formulations and methods of administration
WO2006104892A2
Morinda citrifolia based antifungal formulations and methods
US2006159788A1
Formulation for treating candidiasis using Morinda citrifolia
US2007087108A1
Garcinia mangostana L. enhanced animal food product
EP1711200A2
Type ii diabetes
EP2174649A1
Morinda Citrifolia-Based Oral Care Compositions and Methods
US7264829B2
Morinda citrifolia leaf extract compositions and methods of obtaining the same
